Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/14/2000 | CA2383828A1 26 human secreted proteins |
12/14/2000 | CA2376729A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf) |
12/14/2000 | CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins |
12/14/2000 | CA2376663A1 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use |
12/14/2000 | CA2376642A1 Recombinant nematode nicotinic receptor and uses |
12/14/2000 | CA2376638A1 Muteins of bilin-binding protein |
12/14/2000 | CA2376506A1 Neuromedin b and somatostatin receptor agonists |
12/14/2000 | CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k |
12/14/2000 | CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
12/14/2000 | CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof |
12/14/2000 | CA2376175A1 Vitamin directed dual targeting therapy |
12/14/2000 | CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof |
12/14/2000 | CA2376062A1 Fusion proteins comprising a fragment of a chaperon polypeptide |
12/14/2000 | CA2376058A1 Use of the regulatory subunit of the camp dependent protein kinase (pka) from dictyostelium for camp measurements |
12/14/2000 | CA2376055A1 Spliceosomal protein and its use |
12/14/2000 | CA2376018A1 Angiogenic proteins and uses thereof |
12/14/2000 | CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
12/14/2000 | CA2375876A1 An integrin heterodimer and an alpha subunit thereof |
12/14/2000 | CA2375627A1 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination |
12/14/2000 | CA2375617A1 Targeted angiogenesis |
12/14/2000 | CA2375602A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations |
12/14/2000 | CA2375441A1 Methods for manipulating the avian genome |
12/14/2000 | CA2375424A1 Novel polynucleotides and polypeptides encoded thereby |
12/14/2000 | CA2375409A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development |
12/14/2000 | CA2374851A1 Tek antagonists |
12/14/2000 | CA2374822A1 Molecules for disease detection and treatment |
12/14/2000 | CA2374558A1 Phospholipid transfer protein |
12/14/2000 | CA2371434A1 Compositions and methods for the treatment of tumor |
12/14/2000 | CA2339255A1 Hepg2 cells stably transfected with hcv |
12/13/2000 | EP1059533A1 Method for immunochemically assaying anti-hm1.24 antibody |
12/13/2000 | EP1059358A1 Penicillin binding protein gene and process for producing l-glutamic acid |
12/13/2000 | EP1059355A1 Bacteriocin, its preparation and use |
12/13/2000 | EP1059354A2 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
12/13/2000 | EP1059303A2 Process for dissolution of albumin flakes in a solvent and apparatus for process |
12/13/2000 | EP1058737A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
12/13/2000 | EP1058734A2 Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities |
12/13/2000 | EP1058732A2 Attenuation of bacteria: materials and methods relating thereto |
12/13/2000 | EP1058731A2 Production of mycobacterial polypeptides by lactic acid bacteria |
12/13/2000 | EP1058730A1 Human synapse related glycoproteins (hsrp) |
12/13/2000 | EP1058729A1 Smad binding elements and uses thereof |
12/13/2000 | EP1058728A1 V-like domain binding molecules |
12/13/2000 | EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
12/13/2000 | EP1058723A1 Delivery of proteins into eukaryotic cells with recombinant yersinia |
12/13/2000 | EP1058692A1 Pf4 fragments and pharmaceutical compositions containing same |
12/13/2000 | EP1058691A1 Caspase-8 interacting proteins |
12/13/2000 | EP1058562A1 Compositions and methods of treating tumors |
12/13/2000 | EP1058500A1 The helios gene |
12/13/2000 | EP0914144B1 Therapeutic uses of bpi protein products for human meningococcemia |
12/13/2000 | EP0778781B1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
12/13/2000 | EP0680334B1 Morphogen treatment of gastrointestinal ulcers |
12/13/2000 | CN1276836A Positive-negative selection for homologous recombination |
12/13/2000 | CN1276834A Modified nucleic acid sequences and method for increasing mRNA level and protein expression in cell system |
12/13/2000 | CN1276833A Vaccine |
12/13/2000 | CN1276831A Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems |
12/13/2000 | CN1276797A Low-toxicity human interferon-alpha analog |
12/13/2000 | CN1276796A Biomolecules comprising elastomeric peptide |
12/13/2000 | CN1276731A Insoluble insulin compositions |
12/13/2000 | CN1276729A Heparin-binding growth factor (HBGF) polypeptides |
12/13/2000 | CN1276725A Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
12/13/2000 | CN1276382A Process for preparing recombined human thrombopoietin preparation |
12/13/2000 | CN1276381A Application of growth factor neuregulin and its analogs |
12/13/2000 | CN1276380A Human reduced nicotinamide adenine nucleotie-cytochrome b5 reductase and its coding sequence |
12/13/2000 | CN1276379A Polypeptide-thyrocalcitonin 11 and polynucleotide for coding same |
12/13/2000 | CN1059466C Method for identifying individuals suffering from cellular abnormality |
12/13/2000 | CN1059465C Method for diagnosing disorder by determining expression of GAGE tumor rejection antigen precursors |
12/13/2000 | CN1059447C Polypeptide toxins from spider |
12/12/2000 | US6160208 Genetically engineered cells which express a seed storage protein; for amplification of lysine, methionine and threonine in seeds |
12/12/2000 | US6160206 Porphyrin-accumulating type herbicide resistance gene |
12/12/2000 | US6160202 Regulatory protein which is expressed in recombinant dicot; for modulation of expression of preferential genes |
12/12/2000 | US6160201 Lettuce infectious yellows virus genes |
12/12/2000 | US6160108 Platelet activation protein |
12/12/2000 | US6160107 Nucleic acids encoding antigens associated with polymyositis and dermatomositis |
12/12/2000 | US6160106 Nucleotide sequences which code polypeptides which prevent gene expression; for use as diagnostic screening tools in the detection and treatment of cancer; anticarcinogenic agents |
12/12/2000 | US6160100 Treatment for wilt diseases of trees |
12/12/2000 | US6160099 Anti-human αv β3 and αv β5 antibodies |
12/12/2000 | US6160098 Preparing a fixed erythrocyte transport protein having preferential physical properties; obtain deoxygenated erythrocyte transport protein and controlling physical properties of solution during fixation |
12/12/2000 | US6160097 Regenerating active human polypeptides; freeze liquid containing human polypeptide, lipid and detergent, at a later time melt the liquid |
12/12/2000 | US6160093 Microorganism polypeptide; for the prevention, treatment and diagnosis of microorganismal infection; for use in immunotherapy; anticarcinogenic agents |
12/12/2000 | US6160092 Crystal of the core portion of a signal transducer and activator of transcription (STAT) |
12/12/2000 | US6160091 Transcription factor; for the treatment of genetic disorders; for gene therapy |
12/12/2000 | US6160090 Receptor protein tyrosine phosphatases |
12/12/2000 | US6160089 Cellular signal for the expression of mammalian somatotropin; for the amplification of somatotropin in cells |
12/12/2000 | US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins |
12/12/2000 | US6160087 Peptides having an amino acid sequence from the fimbrial protein of porphyromonas gingivalis and their uses |
12/12/2000 | US6159951 2'-O-amino-containing nucleoside analogs and polynucleotides |
12/12/2000 | US6159949 Polynucleotides, codes and amino acid sequences |
12/12/2000 | US6159937 Immunomodulators |
12/12/2000 | US6159934 Use of GHRH-RP to stimulate stem cell factor production |
12/12/2000 | US6159931 Reaction of insulin with aldehyde and reducing agent and purification |
12/12/2000 | US6159751 Development of DNA probes and immunological reagents of human tumor associated antigens |
12/12/2000 | US6159746 Solid phase immunoassay to detect inhibitors of proteolytic enzymes |
12/12/2000 | US6159735 Controllling transcriptional expression; genetically engineering nucleotide sequences and inserting into an expression vector, transforming a cell and isolate gene product |
12/12/2000 | US6159732 Nucleic acid encoding mammalian Ubr1 |
12/12/2000 | US6159731 Daxx, a Fas-binding protein that activates JNK and apoptosis |
12/12/2000 | US6159729 For recombinant production and vaccines |
12/12/2000 | US6159728 Capsid formed from a coat protein of a bacteriophage and enclosing a foreign moiety linked to an rna sequence of a bacteriophage translational operator which binds to the coat protein; drug delivery; gene therapy |
12/12/2000 | US6159725 Transformed yeast strains |
12/12/2000 | US6159719 Pan-bacterial and pan-fungal identification reagents and methods of use thereof |
12/12/2000 | US6159712 Methods for enhancing the production of interferon in cell culture |
12/12/2000 | US6159711 Amino acid sequences; antiinflammatory agents; treatment of asthma, allergic rhinitis or atopic dermatitis |